Latest round: Growth. Jesse Shefferman is the CEO of Protara Therapeutics, a clinical-stage biotechnology company focused on cancer and rare disease therapies.
Jesse Shefferman is the CEO of Protara Therapeutics, a clinical-stage biotechnology company focused on cancer and rare disease therapies. He leads the company's strategy for de-risked drug development and oversees its portfolio, which includes treatments for bladder cancer and pediatric lymphatic malformations.
Full founder directory · Investor directory · Company funding database · Fundraising library